Funder
Japan Science and Technology Agency
Natural Science Foundation of Hunan Province
Reference81 articles.
1. Myelofibrosis;Passamonti;Blood,2023
2. Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management;Tefferi;Am J Hematol,2021
3. Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management;Tefferi;Am J Hematol,2023
4. Ruxolitinib: a potential treatment for corticosteroid refractory acute graft-versus-host disease;Abedin;Expert Opin Investig Drugs,2020
5. Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial;Rosmarin;Lancet,2020